Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B DysfunctionClaudia Angela Maria Fulgenzi, Calogero Cammà, Naoshi Nishida et al.|JAMA Oncology|2024Cited by 37
UK clinical practice guidelines for the management of patients with constitutional <i>POT1</i> pathogenic variantsOlga Tsoulaki, Helen Hanson, D Gareth Evans et al.|Journal of Medical Genetics|2025Cited by 8
MDM2 inhibitors in sarcomas: results and next stepsIlaria Tortorelli, Robin L. Jones, Andrea Napolitano et al.|Current Opinion in Oncology|2025Cited by 2